Viridian Therapeutics, Inc.\DE

Report date
9/30/2026
Quarter
2026 Q3
Filed
11/4/2026
Shares
1,510
Value ($000)
31
Weight
0.0%
2022 Q2 - 2026 Q3 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).